Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Revolution Medicines, Inc.
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Catharina Ziekenhuis Eindhoven
Eli Lilly and Company
M.D. Anderson Cancer Center
Duke University
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
Novartis
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Compugen Ltd
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
NextCure, Inc.